DrugPatentWatch Database Preview
Profile for Israel Patent: 225010
US Patent Family Members and Approved Drugs for Israel Patent: 225010
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Apr 13, 2032 | Abbvie Inc | VIEKIRA XR | dasabuvir sodium; ombitasvir; paritaprevir; ritonavir |
➤ Sign Up | Apr 13, 2032 | Abbvie Inc | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir |
➤ Sign Up | Apr 13, 2032 | Abbvie Inc | TECHNIVIE | ombitasvir; paritaprevir; ritonavir |
➤ Sign Up | Jun 9, 2031 | Abbvie Inc | VIEKIRA XR | dasabuvir sodium; ombitasvir; paritaprevir; ritonavir |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |